Recall: D-0507-2025

Class II - Potentially Harmful

Class IIClassification
2025-06-19Initiated
OngoingStatus
The Harvard Drug Group LLCFirm

Product

Gabapentin Capsules, USP, 100 mg, 100 capsules (10x10), blister pack cartons, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN, 46268 USA, NDC 0904-6665-61

Reason

Defective container; blister packaging inadequately sealed.

Distribution

Nationwide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.